ISCO (International Stem Cell) Institutional Ownership: 2.57% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISCO International Stem Cell Corp ISCO
28 GF Score
Price $0.30
GF Value $0.13
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is International Stem Cell Institutional Ownership?

International Stem Cell ISCO +19.96% 28 Institutional Ownership is 2.57% as of Aug. 07, 2026. GuruFocus rates ISCO with a GF Score™ of 28/100 and a GF Value™ of $0.13 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, International Stem Cell's institutional ownership is 2.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, International Stem Cell's Insider Ownership is 35.98%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, International Stem Cell's Float Percentage Of Total Shares Outstanding is 44.88%.

International Stem Cell Institutional Ownership Historical Data

* Premium members only.

The historical data trend for International Stem Cell's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Stem Cell Institutional Ownership Chart

International Stem Cell Historical Data

The historical data trend for International Stem Cell can be seen below:

2012-03-31 2012-04-30 2012-05-31 2012-06-30 2012-07-31 2012-08-31 2012-09-30 2012-10-31 2012-11-30 2012-12-31
Institutional Ownership 2.58 2.58 2.58 2.58 2.58 2.58 2.57 2.57 2.57 2.57
ISCO
28GF Score
International Stem Cell Corp ISCO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

International Stem Cell Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.57% mean?
International Stem Cell (ISCO) has a Institutional Ownership of 2.57% as of Aug. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on International Stem Cell and its competitors.
Is International Stem Cell's Institutional Ownership too high?
International Stem Cell's current Institutional Ownership is 2.57%. Overall, International Stem Cell has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does International Stem Cell's Institutional Ownership compare to GRI and VRAX?
International Stem Cell's Institutional Ownership of 2.57% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on International Stem Cell and its competitors. International Stem Cell's current Institutional Ownership is 2.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Stem Cell stock overvalued right now?
Based on GuruFocus' analysis, International Stem Cell (ISCO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.13, compared to a current price of $0.30 — trading 130.7% above its estimated fair value. The current Institutional Ownership is 2.57%. International Stem Cell's overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For International Stem Cell (ISCO), the current Institutional Ownership is 2.57% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is International Stem Cell (ISCO) Overvalued in 2026?

Based on GuruFocus' analysis, International Stem Cell stock appears to be overvalued. The current stock price of $0.30 is trading 130.7% above its estimated GF Value™ of $0.13. GuruFocus considers International Stem Cell to be Significantly Overvalued.

Key valuation signals for ISCO:

  • Institutional Ownership: 2.57%
  • GF Value™: $0.13 vs. price of $0.30 (130.7% above fair value)
  • GF Score™: 28/100 with 6 warning signs

No single metric tells the full story. See the ISCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

International Stem Cell Business Description

Address 9745 Businesspark Avenue, San Diego, CA, USA, 92131
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. The company operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
28GF Score

Get the complete analysis for ISCO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$0.13
GF Value